IFNA1 and COVID-19: Inflammatory cytokine (IL-6, IL-1, and IFN) blockade, stem cell therapy, immune cell reduction, transfusion of convalescent plasma, and artificial extracorporeal liver support are all potential therapies for COVID-19 (Al-Qahtani et al., 2017), and we believe that IL-6 blockade is a viable technique for COVID-induced CRS.